1638759-79-1

Basic information

• Product Name: methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate
• Synonyms: 1H-Indazole-6-carboxylic acid, 4-bromo-1-methyl-, methyl ester
• CAS NO: 1638759-79-1
• Molecular Formula: C10H9BrN2O2
• Molecular Weight: 269.09466
• EINECS: -0
• Mol File: 1638759-79-1.mol

Chemical Properties

• Boiling Point: 363.5±22.0 °C(Predicted)
• Appearance: /
• Density: 1.61±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -1.05±0.30(Predicted)
• CAS DataBase Reference: methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate(1638759-79-1)
• EPA Substance Registry System: methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate(1638759-79-1)

Safety Data

• Hazardous Substances Data: 1638759-79-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
Methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Research:
methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate serves as a building block in the creation of agrochemicals, contributing to the development of new pesticides or herbicides with improved efficacy and selectivity.
Used in Material Science:
Methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate is employed as a component in the development of new materials with specific properties, such as optical, electronic, or magnetic characteristics, due to its unique molecular structure.
Used in Organic Synthesis:
As an indazole derivative, methyl 4-bromo-1-methyl-1H-indazole-6-carboxylate is used as a versatile building block in organic synthesis, enabling the creation of a wide range of organic compounds for various applications.

Upstream product

• 882679-96-1 methyl 4-bromo-1H-indole-6-carboxylate 
• 223519-08-2 methyl 3-bromo-4-methyl-5-nitrobenzoate 
• 223519-11-7 methyl 3-amino-5-bromo-4-methylbenzoate 
• 96-98-0 4-methyl-3-nitrobenzoic acid 
• 34545-20-5 3-bromo-4-methyl-5-nitro-benzoic acid 
• 885518-47-8 methyl 4-bromo-1H-indazole-6-carboxylate 
• 74-88-4 methyl iodide 

Relevant articles and documents

SUBSTITUTED HETEROCYCLIC AMIDE COMPOUND AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF

Provided are a substituted heterocyclic amide compound having a selective inhibitory effect on RIPK1, and a pharmaceutically acceptable salt, a stereoisomer, a solvate or a prodrug thereof, and a pharmaceutical composition containing the compound, and the

Modulators of STING (Stimulator of Interferon Genes)

Compounds of the general formula (I): or a pharmaceutically acceptable salt thereof, processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.

SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE

The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell pr

CARBOXY SUBSTITUTED (HETERO) AROMATIC RING DERIVATIVES AND PREPARATION METHOD AND USES THEREOF

Carboxy-substituted (hetero)aryl derivatives, pharmaceutical compositions comprising these compounds, and methods of preparing such compounds and compositions are provided. The compounds or compositions are useful in inhibiting xanthine oxidase and urate anion transporter 1, and also can be used in the treatment or prevention of diseases associated with high blood uric acid level in mammals, especially humans.